Equities

Creo Medical Group PLC

Creo Medical Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)34.24
  • Today's Change-0.51 / -1.47%
  • Shares traded150.81k
  • 1 Year change+38.34%
  • Beta1.1511
Data delayed at least 20 minutes, as of Mar 28 2024 11:47 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.

  • Revenue in GBP (TTM)29.23m
  • Net income in GBP-25.10m
  • Incorporated2016
  • Employees279.00
  • Location
    Creo Medical Group PLCUnit 2 Beaufort Park,, Beaufort Park WayCHEPSTOW NP16 5UHUnited KingdomGBR
  • Phone+44 129 160 6005
  • Websitehttps://creomedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
e-Therapeutics plc475.00k-8.27m65.15m38.00--1.96--137.17-0.0154-0.01540.00090.05680.0148--1.9212,500.00-25.79-33.25-27.10-35.11100.00100.00-1,741.90-1,490.90----0.0089---0.4193---2.53--24.22--
Redx Pharma PLC4.20m-33.16m72.93m101.00--18.72--17.36-0.099-0.0990.01260.010.0954--135.5541,603.96-75.26-52.99-166.19-88.10-----789.05-206.66----0.8405---77.52100.71-84.15--8.12--
Scancell Holdings Plc0.00-11.32m95.10m51.00---------0.0138-0.01380.00-0.01020.00----0.00-37.31-33.32-40.52-35.82-------817.98----1.73-------161.24--77.85--
Faron Pharmaceuticals Oy0.00-26.51m96.33m40.00---------0.4095-0.40950.00-0.21710.00-------287.97-213.06---963.12-----------12.02---------7.71---16.05--
Futura Medical PLC1.70m-5.11m116.96m12.00--14.48--68.66-0.0177-0.01770.00590.02680.1796--3.40141,954.20-53.82-75.22-66.35-106.1253.37---299.73-88,144.944.15--0.00-------17.93--67.85--
4Basebio PLC354.00k-6.28m121.65m----34.31--343.64-0.5094-0.50940.02870.27690.02960.39774.88---52.42---60.21--80.51---1,772.60--3.28-40.290.6683---20.71---59.20------
Creo Medical Group PLC29.23m-25.10m125.61m279.00--1.77--4.30-0.1139-0.11390.1260.19660.33181.874.14102,926.10-28.49---34.24--48.11---85.87--3.45--0.1177--7.98---9.52------
Animalcare Group Plc70.04m1.16m126.23m220.00110.121.5714.201.800.01910.01911.161.340.60472.515.06318,372.701.000.08771.210.102657.5952.041.660.15621.158.030.12232,044.86-3.25--2,651.95------
Allergy Therapeutics plc59.59m-43.07m142.99m635.00--24.93--2.40-0.0293-0.02930.04090.00120.8532.296.7993,837.80-61.65-11.59-83.55-15.1555.7970.08-72.28-11.781.18-16.530.9457---18.11-2.71-212.65--16.41--
Avacta Group Plc16.03m-42.08m171.75m120.00--5.93--10.72-0.1605-0.16330.06060.08260.24064.502.38133,541.70-63.18---119.23--54.40---262.60--0.6603-1.660.6913--228.22---49.92------
Data as of Mar 28 2024. Currency figures normalised to Creo Medical Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

37.85%Per cent of shares held by top holders
HolderShares% Held
Canaccord Genuity Wealth Ltd.as of 19 Mar 202439.30m10.87%
M&G Investment Management Ltd.as of 31 Oct 202333.61m9.30%
Amati Global Investors Ltd.as of 31 Jan 202415.71m4.35%
Baillie Gifford & Co.as of 31 Dec 202212.54m3.47%
SVM Asset Management Ltd.as of 30 Jun 202310.62m2.94%
AXA Investment Managers UK Ltd.as of 31 Dec 20227.99m2.21%
Chelverton Asset Management Ltd.as of 30 Jun 20237.50m2.08%
Octopus Investments Ltd.as of 29 Feb 20243.70m1.02%
Border to Coast Pensions Partnership Ltd.as of 30 Sep 20233.36m0.93%
BlackRock Investment Management (UK) Ltd.as of 30 Sep 20232.49m0.69%
More ▼
Data from 30 Sep 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.